tiprankstipranks
Trending News
More News >
Petmed Express (PETS)
NASDAQ:PETS
Advertisement

Petmed Express (PETS) Price & Analysis

Compare
849 Followers

PETS Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Financial StabilityThe business is well-capitalized to make it through the turnaround, with $50M of cash and no debt.
Management StrategyThe new strategy is focused on consolidating brands, improving the supply chain, focusing on customer retention, driving site traffic, improving the marketing approach, and upgrading the technology platforms.
Bears Say
Customer RetentionThe company is likely losing customers to competitors with the absence of promotions.
Financial PerformanceThe business has not shown growth on an organic basis in over 12 quarters, which is largely driven by competitive pressures.
Revenue DeclineQ2 revenue declined 16% to $59.6M, which was below the $66.0M estimate, indicating customers reduced spending or sought promotions from competitors.

Financials

Ownership Overview

29.05%13.84%0.57%49.90%
29.05% Insiders
0.57% Other Institutional Investors
49.90% Public Companies and Individual Investors

PETS FAQ

What was Petmed Express’s price range in the past 12 months?
Petmed Express lowest stock price was $2.90 and its highest was $6.85 in the past 12 months.
    What is Petmed Express’s market cap?
    Petmed Express’s market cap is $64.04M.
      When is Petmed Express’s upcoming earnings report date?
      Petmed Express’s upcoming earnings report date is Jul 28, 2025 which is in 10 days.
        How were Petmed Express’s earnings last quarter?
        Petmed Express released its earnings results on Jul 01, 2025. The company reported -$0.34 earnings per share for the quarter, missing the consensus estimate of -$0.015 by -$0.325.
          Is Petmed Express overvalued?
          According to Wall Street analysts Petmed Express’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Petmed Express pay dividends?
            Petmed Express pays a Quarterly dividend of $0.3 which represents an annual dividend yield of N/A. See more information on Petmed Express dividends here
              What is Petmed Express’s EPS estimate?
              Petmed Express’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Petmed Express have?
              Petmed Express has 20,656,458 shares outstanding.
                What happened to Petmed Express’s price movement after its last earnings report?
                Petmed Express reported an EPS of -$0.34 in its last earnings report, missing expectations of -$0.015. Following the earnings report the stock price went down -1.506%.
                  Which hedge fund is a major shareholder of Petmed Express?
                  Currently, no hedge funds are holding shares in PETS

                  Company Description

                  Petmed Express

                  PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Fonar
                  So-Young International
                  Vor Biopharma
                  Climb Bio
                  Zura Bio
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis